668261-31-2

Upstream product

• 10130-89-9 p-carboxyphenylsulfonyl chloride 
• 932-96-7 N-methyl(p-chloroaniline) 

Downstream Products

• 666859-77-4 4-{ [ (4-CHLOROPHENYL) (methyl) amino] SULFONYL} benzoyl chloride 
• 666859-53-6 N-(4-BROMO-2-CYANOPHENYL)-4-{ [ (4-chlorophenyl) (methyl) amino] sulfonyl} benzamide 
• 946160-84-5 C₂₂H₁₈BrClN₂O₄S 
• 666859-78-5 methyl 5-bromo-2-[(4-{[(4-chlorophenyl)(methyl)amino]sulfonyl}benzoyl)amino]benzoate 
• 1354560-51-2 methyl 2-[(4-{[(4-chlorophenyl)(methyl)amino]sulfonyl}benzoyl)amino]-5-cyanobenzoate 

Relevant academic research and scientific papers

Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell

Provided herein are novel compounds, pharmaceutical compositions for use, inter alia, in methods of reducing Wnt-mediated effects and treating cancer.

Structure-activity relationships of bioisosteres of a carboxylic acid in a novel class of bacterial translation inhibitors

The discovery and initial optimization of a novel anthranilic acid derived class of antibacterial agents which suffered from extensive protein binding has been previously reported. The structure-activity relationships around the carboxylic acid substituent are described herein. This acid was replaced by several alternative functional groups in attempts to retain bioactivity while reducing protein binding. Only groups with an acidic proton retained activity, and analogs containing those groups maintained the protein binding inherent to this class of antibacterial agents.

Discovery and initial development of a novel class of antibacterials: Inhibitors of Staphylococcus aureus transcription/translation

The novel bacterial transcription/translation (TT) inhibitor 1 was identified through a combination of high throughput screening and exploratory medicinal chemistry. Initial optimization of the anthranilic acid moiety and sulfonamide amine diversity was accomplished via 1- and two-dimensional solution phase libraries, resulting in an improvement in the MIC of the lead from 64 to 8 μg/mL (compound 4l). Subsequent modification of the central aromatic ring and further refinement of the sulfonamide amines required the development of a solid phase route on Wang resin. The resulting libraries generated a number of potent antibacterials with MICs of ≤1 μg/mL (e.g., 10b, 12, and 13). During the course of this work, it became apparent that the antibacterial activity of the series is not fully correlated with TT inhibition, suggesting that at least one additional mechanism of action is operative.

ANTIBACTERIAL AGENTS

The present invention relates to antibacterial agents that are useful for sterilization, sanitation, antisepsis, and disinfection.